NYSEARCA:XBISPDR S&P Biotech ETF Stock Price, Forecast & News

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, XBI stock has increased by 39.5% and is now trading at $110.20.
View which stocks have been most impacted by COVID-19.

SPDR S&P Biotech ETF announced a quarterly dividend on Friday, December 20th. Stockholders of record on Monday, December 23rd will be given a dividend of $0.0009 per share on Thursday, December 26th. This represents a $0.00 annualized dividend and a dividend yield of 0.00%. The ex-dividend date is Friday, December 20th.
View SPDR S&P Biotech ETF's dividend history.

News stories about XBI stock have been trending negative on Saturday, InfoTrie reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. SPDR S&P Biotech ETF earned a news impact score of -2.7 on InfoTrie's scale. They also assigned news articles about the exchange traded fund a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about SPDR S&P Biotech ETF.

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include NVIDIA (NVDA), Intel (INTC), iShares Nasdaq Biotechnology ETF (IBB), Micron Technology (MU), Cisco Systems (CSCO), Walt Disney (DIS), Pfizer (PFE), Gilead Sciences (GILD), Netflix (NFLX) and Advanced Micro Devices (AMD).

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

SPDR S&P Biotech ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Kellogg W K Foundation Trust (0.48%), Papp L Roy & Associates (0.43%), Whittier Trust Co. (0.41%), Bank of Montreal Can (0.40%), American Financial Advisors LLC (0.35%) and Howard Capital Management (0.33%).

XBI stock was sold by a variety of institutional investors in the last quarter, including Bank of Nova Scotia, SG Americas Securities LLC, Meitav Dash Investments Ltd., Cumberland Advisors Inc., Cornerstone Advisory LLC, Tocqueville Asset Management L.P., Hartline Investment Corp, and BTR Capital Management Inc..

XBI stock was purchased by a variety of institutional investors in the last quarter, including Kellogg W K Foundation Trust, Bank of Montreal Can, LVM Capital Management Ltd. MI, Stifel Financial Corp, Kerrisdale Advisers LLC, Eqis Capital Management Inc., Evolution Wealth Advisors LLC, and PNC Financial Services Group Inc..

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of XBI stock can currently be purchased for approximately $110.20.

SPDR S&P Biotech ETF has a market capitalization of $5.72 billion.

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.